Cardiovascular Benefits of SGLT2 Inhibitor in Diabetic Patients during Early-Phase Acute Myocardial Infarction Care

Published: 21 March 2025| Version 1 | DOI: 10.17632/6h29fz6fnf.1
Contributor:
Sheng-Fan Wang

Description

Supplementary: Cardiovascular Benefits of SGLT2 Inhibitor in Diabetic Patients during Early-Phase Acute Myocardial Infarction Care

Files

Institutions

  • Taipei Veterans General Hospital

Categories

Data Analysis

Licence